Discover
DCOY
Decoy Therapeutics Inc.
5.30
1 x 5.18
1 x 5.53
bid
ask
+
0.38
7.72%
11:44 AM
timesize
| Ytd | -42.64% | |
| 1y | -42.64% |
4.90
day range
5.35
4.32
52 week range
415.80
| Open | 5.00 | Prev Close | 4.92 | Low | 4.90 | High | 5.35 | Mkt Cap | 2.62M |
| Vol | 7.66K | Avg Vol | 229.10K | EPS | -112.73 | P/E | -0.04 | Forward P/E | N/A |
| Beta | 0.59 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 6.33 | 200-d Avg | 13.03 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 2.28M | ||
| Research and Development Expense | 749.81K | ||
| Selling, General and Administrative Expense | 1.53M | ||
| Operating Income | -2.28M | ||
| Net Income | -2.22M | ||
| Net Income Common Stock | -2.22M | ||
| Net Income Common Stock (USD) | -2.22M | ||
| Consolidated Income | -2.22M | ||
| Earnings per Basic Share | -4.18 | ||
| Earnings per Basic Share (USD) | -4.18 | ||
| Earnings per Diluted Share | -4.18 | ||
| Earning Before Interest & Taxes (EBIT) | -2.22M | ||
| Earning Before Interest & Taxes (USD) | -2.22M | ||
| Weighted Average Shares | 531.97K | ||
| Weighted Average Shares Diluted | 531.97K | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.82M | ||
| Cash and Equivalents (USD) | 7.82M | ||
| Current Assets | 8.36M | ||
| Property, Plant & Equipment Net | 35.74K | ||
| Total Assets | 8.42M | ||
| Current Liabilities | 4.55M | ||
| Total Liabilities | 4.55M | ||
| Accumulated Retained Earnings (Deficit) | -96.67M | ||
| Shareholders Equity | 3.88M | ||
| Shareholders Equity (USD) | 3.88M | ||
| Assets Non-Current | 65.62K | ||
| Deferred Revenue | 3.23M | ||
| Trade and Non-Trade Payables | 1.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.92K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.89M | ||
| Net Cash Flow from Operations | -2.89M | ||
| Share Based Compensation | 213.04K | ||